Patients are Our Passion

The right drugs, the right knowledge and the right people can transform everyday decisions into everyday triumphs.

Learn More
Our Product
NUZYRA®  is an FDA-approved tetracycline-class antibiotic designed to address a significant unmet need for adult patients with CABP and ABSSSI caused by susceptible bacteria.
Learn More
Groundbreaking Innovators
A disciplined team with proven capabilities in developing and commercializing new treatment options for complex medical issues.

Meet Our Team
Powered by You
Our employees are experienced, committed, and driven to build a company that saves lives. Learn more about how you can join our team.
View Open Roles

Taking on the Challenge of Antimicrobial Resistance (AMR)

“Antibacterial therapy is necessary in order to be able to be effective as a country in dealing with a global pandemic.”

Dr. Evan Loh, M.D. CEO, Paratek

Learn More

Taking on the Challenge of Antimicrobial Resistance (AMR)

Gaps in pandemic preparedness go beyond the bioterrorism space to resistant-bacteria pathogens and viral infections.

Learn More

Taking on the Challenge of Antimicrobial Resistance (AMR)

AMR is a deadly health threat that according to recent estimates takes the lives of 160,000 Americans each year. It is an ongoing pandemic that will worsen unless we are able to provide new technologies to defeat superbugs.

Learn More
Healthcare Professionals

Taking on the Challenge of Antimicrobial Resistance (AMR)

AMR is a deadly health threat that according to recent estimates takes the lives of 160,000 Americans each year. It is an ongoing pandemic that will worsen unless we are able to provide new technologies to defeat superbugs.

Learn More
Healthcare Professionals

Taking on the Challenge of Antimicrobial Resistance (AMR)

“Antibacterial therapy is necessary in order to be able to be effective as a country in dealing with a global pandemic.”

Learn More
Healthcare Professionals

Taking on the Challenge of Antimicrobial Resistance (AMR)

Gaps in pandemic preparedness go beyond the bioterrorism space to resistant-bacteria pathogens and viral infections.

Learn More
Recent Press

Paratek in the News

View All